Hand Dexterity Training in Degenerative Cervical Myelopathy (DCM)

December 20, 2024 updated by: Aditya Vedantam, Medical College of Wisconsin

Virtual Reality-Based Hand Rehabilitation for Post-Surgical Degenerative Cervical Myelopathy: A Pilot Study

This clinical study aimed to evaluate the effectiveness of a virtual reality-based training intervention for improving hand dexterity and promoting neuroplasticity in individuals with Degenerative Cervical Myelopathy (DCM) after surgical decompression. Participants completed a 4-week training program using the Virtual Keyboard (VK) system, which facilitated repetitive, individualized finger movements in a virtual environment. Outcomes were measured pre- and post-training to quantify improvements in hand dexterity, quality of life, and cortical motor activity.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Degenerative Cervical Myelopathy (DCM) is a leading cause of non-traumatic spinal cord injury, often resulting in impaired hand dexterity and diminished quality of life. Despite surgical decompression being the primary treatment, over 30% of individuals experience persistent functional disability due to a lack of targeted post-surgical rehabilitative interventions. This study sought to address this clinical gap by implementing and evaluating a virtual reality-based hand training intervention.

The central hypothesis was that an intensive, individualized training program using the Virtual Keyboard (VK) system would improve hand dexterity in individuals with DCM and that these functional gains would be supported by measurable changes in cortical motor activity.

Study Design

This single-arm interventional study recruited participants who had undergone cervical spine surgery within six months. A total of 25 participants were enrolled, each completing:

A 4-week training program consisting of 12 one-hour sessions using the VK system. The system provided engaging, interactive tasks designed to promote finger individuation and precise motor control through real-time visual and auditory feedback.

Pre- and post-training evaluations assessing functional, neurophysiological, and quality-of-life outcomes.

Specific Aims- Aim 1: Quantify improvements in hand dexterity after the training intervention. Hypothesis: Training with the VK system would significantly improve hand function as measured by the Jebsen-Taylor Hand Function Test (JTHFT) and other clinical metrics.

Approach: Baseline, post-training, and follow-up evaluations measured outcomes including JTHFT scores, pinch strength, and sensorimotor tests.

Aim 2: Assess neuroplastic changes associated with training. Hypothesis: The training program would enhance cortical motor activation and connectivity, reflected in changes in beta-band event-related desynchronization (ERD) and coherence measured via quantitative EEG (qEEG).

Approach: Participants underwent qEEG during finger-tapping tasks at each evaluation, and EEG data were analyzed for changes in cortical activation patterns.

Outcomes and Measures- Primary outcomes included: Improvement in hand function as measured by JTHFT scores and related clinical tests.

Changes in cortical motor activity and connectivity, including event-related desynchronization and coherence, derived from qEEG data.

Secondary outcomes included quality-of-life measures (SF-36 physical component score and EuroQol 5D).

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53233
        • Marquette University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosed with Degenerative Cervical Myelopathy.
  • Completed cervical spine surgery within 6 months.
  • Modified Japanese Orthopaedic Association (mJOA) upper limb motor score between 1-4.

Exclusion Criteria:

  • Pregnancy.
  • History of brain or upper extremity surgery within the past year.
  • Significant arm/hand pain limiting movement.
  • Complete paralysis of the hands (mJOA=0).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality Training Group
Participants completed virtual reality-based hand training using the virtual keyboard system.
Participants underwent a 4-week training program comprising 12 one-hour sessions to enhance finger individuation and motor control using a virtual reality platform.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Jebsen-Taylor Hand Function Test
Time Frame: Baseline, post-training and follow-up.
The Jebsen-Taylor Hand Function Test (JTHFT) is a standardized test used to assess hand function during everyday activities. It consists of seven timed subtests, such as writing, card turning, and object manipulation. The outcome is recorded as the time taken to complete each task in seconds, where lower times indicate better hand function.
Baseline, post-training and follow-up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quantitative Electroencephalograms (qEEG)
Time Frame: Baseline, post-training and follow-up.
Beta-band event-related desynchronization (ERD) and cortical coherence are key neural markers often analyzed during finger-tapping tasks to study motor control and cortical connectivity. These measures are often used in clinical studies (e.g., DCM, stroke) to evaluate motor system integrity and changes due to interventions or disease progression.
Baseline, post-training and follow-up.
Nine-Hole Peg Test (9HPT)
Time Frame: Baseline, post-training and follow-up.
The Nine-Hole Peg Test (9HPT) is a standardized test used to measure finger dexterity. It involves placing and removing pegs from nine holes as quickly as possible. The outcome is recorded as the time taken in seconds, where lower times indicate better dexterity.
Baseline, post-training and follow-up.
Box and Blocks Test (BBT)
Time Frame: Baseline, post-training and follow-up.
The Box and Blocks Test is a measure of gross manual dexterity. It involves moving as many blocks as possible from one compartment of a box to another in 60 seconds. The score is the total number of blocks moved, where higher scores indicate better manual dexterity.
Baseline, post-training and follow-up.
QuickDASH
Time Frame: Baseline, post-training and follow-up.
The QuickDASH is a subset of 11 items from the 30-item DASH (Disabilities of the Arm, Shoulder, and Hand) and is a self-reported questionnaire in which the response options are presented as 5-point Likert scales. Lower scores indicate better outcomes.
Baseline, post-training and follow-up.
Three-point pinch strength
Time Frame: Baseline, post-training and follow-up.
Sensorimotor hand function 3-point pinch strength using a pinch gauge (PG-60, B&L Engineering) measured in pounds (lbs.).
Baseline, post-training and follow-up.
Touch sensitivity
Time Frame: Baseline, post-training (1 week after VK training), and 4-week follow-up ( 4 weeks after VK training).
Touch sensitivity of the palmar and dorsal hand using von Frey filaments (Aesthesio®), scored out of 12 (12 indicates full sensation)
Baseline, post-training (1 week after VK training), and 4-week follow-up ( 4 weeks after VK training).
EuroQol 5-Dimension score
Time Frame: Baseline, post-training and follow-up.
The EuroQol 5-Dimension (EQ-5D) is a standardized measure of health-related quality of life. The minimum level sum score (LSS) is derived by summing the responses across the five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), each scored from 1 (no problems) to 3 (extreme problems) score is 5, and the maximum score is 15, where higher scores indicate worse health status. It also includes a Visual Analog Scale (VAS) scored from 0 to 100, where higher scores indicate better health.
Baseline, post-training and follow-up.
Short Form-36 Health Survey version 2
Time Frame: Baseline, post-training and follow-up.
The Short Form-36 Health Survey version 2 (SF-36v2) is a validated, comprehensive measure of health-related quality of life. It includes eight domains (e.g., physical functioning-physical component score (PCS), and mental health-mental component score (MCS)) with scores ranging from 0 to 100, where higher scores indicate better health and functioning. An overall summary score for physical and mental health can also be derived.
Baseline, post-training and follow-up.
Modified Japanese Orthopedic Association scale
Time Frame: Baseline, post-training and follow-up.
The Modified Japanese Orthopaedic Association (mJOA) Score is a clinical scale used to evaluate the severity of cervical myelopathy. It assesses motor function in the upper and lower extremities, sensation, and bladder function. The total score ranges from 0 to 18, where higher scores indicate better neurological function and less severe disability.
Baseline, post-training and follow-up.
Myelopathy Disability Index
Time Frame: Baseline, post-training and follow-up.
The Myelopathy Disability Index (MDI) is a validated measure used to assess disability in individuals with cervical myelopathy. It consists of 10 items, each scored from 0 (no disability) to 10 (severe disability). The total score ranges from 0 to 100, where higher scores indicate greater disability.
Baseline, post-training and follow-up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aditya Vedantam, MD, Medical College of Wisconsin

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 19, 2023

Primary Completion (Actual)

October 23, 2024

Study Completion (Actual)

October 23, 2024

Study Registration Dates

First Submitted

December 17, 2024

First Submitted That Met QC Criteria

December 20, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 20, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • PRO00044319
  • PI: Vedantam (Other Grant/Funding Number: Advancing a Healthier Wisconsin Endowment)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Due to confidentiality and privacy concerns, individual participant data (IPD) will not be shared with other researchers. All study data will be presented in aggregate form in the final published results, with appropriate measures taken to ensure participant anonymity and data security.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Degenerative Cervical Myelopathy

Clinical Trials on Virtual Keyboard (VK) System

Subscribe